PKU Healthcare

PKU Healthcare

Logo of PKU Healthcare Group (left), calligraphy of "PKU Healthcare" (top right) and English name (bottom right)
Formerly	Southwest Synthetic Pharmaceuticals
Company type	public
Traded as	SZSE: 000788
Industry	pharmaceutical
Headquarters	Chongqing , China
Revenue	CN¥2.011 billion (2015)
Operating income	(CN¥045 million) (2015)
Net income	CN¥0025 million (2015)
Total assets	CN¥3.124 billion (2015)
Total equity	CN¥1.133 billion (2015)
Owner	PKU Healthcare Group (40.38%) China Securities Finance (01.94%) public shareholders (57.68%)
Parent	SW Pharmaceutical Group (direct) PKU Healthcare Group (intermediate) Founder Group (intermediate) PKU Asset Management (intermediate) Peking University (intermediate) Ministry of Education (intermediate) State Council (ultimate)
Website	pku-hc.com
Footnotes / references in consolidated financial statement

PKU Healthcare Co., Ltd. formerly known as PKU International Healthcare Group Southwest Pharmaceutical Co., Ltd., is a Chinese pharmaceutical company. The major shareholder was PKU Healthcare Group, a subsidiary of PKU Founder Group. PKU Founder Group itself is a subsidiary of Peking University, in turn making the listed company a state-owned enterprise by broader definition.